Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study

ConclusionTα1 use in COVID-19 patients was associated with an increased non-recovery rate, especially in those with greater disease severity.
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research